Displaying items by tag: school of medicine

Similar to the ancient Greek legend of the Trojan horse, platelets in a transgenic mouse deliver a life-saving enzyme.
Curtis A. Carver Jr., Ph.D., comes to UAB from the Board of Regents of the University System of Georgia, where he served as vice chancellor and chief information officer.
Kidney recipients infected only with HIV do as well as uninfected recipients, but HIV-infected recipients co-infected with hepatitis C virus have poorer outcomes.
A new comprehensive textbook on neurological diseases and conditions from the desk of a UAB neuroscientist will be available this spring.
UAB ophthalmologists are racing to save our sight. While the number of Americans with glaucoma could double by 2050, UAB’s team of specialists and scientists is expanding knowledge about the disease. Discover how expert care, clever inventions, and engineering ingenuity could lead to early detection and new treatments in UAB Magazine.
School of Health Professions’ master’s in health administration program moves up three spots to No. 2 in the United States.
Harvey Makadon, M.D., director of the National LGBT Health Education Center at the Fenway Institute, will be at UAB on March 11.
Match Day, when fourth-year medical students learn their residency assignments, is March 20 in the Alabama Theater.
Tagged under
The 15th annual UAB School of Medicine art show kicks off March 17.
5K Color Run hosted by Oak Mountain High School students to raise money for cancer research at UAB.
Guest speaker and former Surgeon General Regina Benjamin among many who will see new approaches and successful models of current health-disparities research.
Previous research indicated six weeks of treatment improved hearing, but new findings published in the New England Journal of Medicine reveal six months is better.
A little more than a year since he suffered major injuries in the January 2014 snowstorm, Kelly Garner and his UAB orthopedics team were showing the world just how far he has come.
Donation from Dai-ichi Life Insurance Company and Protective Life Corporation will aid new disease-changing therapies in the ADDA pipeline.
Page 130 of 170